Europe — EMA

Levetiracetam Aurovitas

Request sourcing

Pack/s

What is Levetiracetam?

Levetiracetam, the active ingredient in Levetiracetam Aurovitas, is an anticonvulsant presented as a tablet for oral use. It treats seizure disorders, particularly focal onset seizures, in adults and children. GNH USA supplies Levetiracetam Aurovitas as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Levetiracetam Aurovitas as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Levetiracetam used for?

Levetiracetam is used in the management of seizure disorders, acting on neuronal excitability pathways.

- Focal onset seizures: Reduces frequency of seizures in patients with focal epilepsy. - Primary generalized tonic‑clonic seizures: Controls seizure activity in generalized epilepsy. - Myoclonic seizures: Decreases seizure episodes in patients with myoclonic epilepsy.

What are the side effects of Levetiracetam?

The …

What precautions apply to Levetiracetam?

...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →